Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)

Also known as: Epstein-Barr Virus-Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD) / EBV-Related Post-Transplant Lymphoproliferative Disorder / EBV+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD) / EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD) / EBV-Related PTLD / Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09035Nivolumab1Completed1
DB15419Nanatinostat2Recruiting1
DB00073Rituximab2Active Not Recruiting1
DB17072Tabelecleucel2Recruiting1
DB01610Valganciclovir2Recruiting1
DB17072Tabelecleucel3Completed1
DB17072Tabelecleucel3Recruiting1
DB17072TabelecleucelNot AvailableNo Longer Available1